SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
45 hedge funds and large institutions have $62.3M invested in Sinovac Biotech, Ltd in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 7 closing their positions.
Holders
45
Holders Change
-5
Holders Change %
-10%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
16
Reduced
20
Closed
7
Calls
$65K
Puts
$150K
Net Calls
-$85K
Net Calls Change
+$455K
Top Buyers
1 |
O
1
OrbiMed
New York
|
$13.6M |
2 |
PRCM
2
Pine River Capital Management
Minnetonka,
Minnesota
|
$5.27M |
3 |
3
Wellington Management Group
Boston,
Massachusetts
|
$20.5M |
4 |
4
Morgan Stanley
New York
|
$853K |
5 |
5
Renaissance Technologies
New York
|
$6.09M |